Rochester,NY 9/2/2009 2:43:35 AM
News / Business

CERS Cerus Corporation, Opened at 2.14, spikes to 2.19 and settles to 1.96 in the Late After noon

Cerus Corporation

Cerus Corporation, a biomedical products company, engages in the development and commercialization of the INTERCEPT Blood System, began the day at 2.14, spikes to 2.19 on volume of 1,527,772 shares. During the Late Aftre noon the stock Ranged from 1.96 - 2.19.

http://StockEinstein.com
offers free daily stock alerts on companies ready to run. Scroll to BOTTOM of this page for free stock alerts, or visit our site.

About Cerus Corporation.

Cerus Corporation, a biomedical products company, engages in the development and commercialization of the INTERCEPT Blood System. The company?s INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. It markets the INTERCEPT system for platelets and plasma primarily in Europe, the Russian Federation, and the Middle East. The company is also developing INTERCEPT Blood System for red blood cells or red blood cell system, which is designed to inactivate blood-borne pathogens in donated red blood cells for transfusion. It has collaboration agreements with Baxter International, Inc., BioOne Corporation, and Laboratorios Grifols S.A., as well as the United States Armed Forces. The company was founded in 1991 and is based in Concord, California.

About Stock Einstein

StockEinstein
uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance.  We utilize not only software, but time tested criteria to uncover these potential winners.  When these benchmarks are reached or exceeded, our subscribers are immediately notified.

This service is free and available only to subscribers. 
Scroll to the bottom of this page to signup for free stock alerts and visit our site.

Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php

IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment.  Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses.  Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.